Takeda chief apologizes over data misuse in drug ad

Takeda chief apologizes over data misuse in drug ad

TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.

  • Product Code
  • ILEA001195597
  • Registered date
  • 2014/3/03 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2014 Kyodo News
  • Media size
  • 2537 × 3222 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 645.94(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Anti-Alzheimer's drug lecanemab

    Anti-Alzheimer's drug lecanemab

    Haruo Naito, CEO of Japanese pharmaceutical company Eisai Co., attends a press conference in Tokyo on Dec. 13, 2023, as the company's anti-Alzheimer's drug lecanemab is set to be launched on Dec. 20, following a health ministry advisory body's approval of its coverage by the Japanese public insurance scheme.
      Avigan could be formally approved as Ebola drug early 2015

      Avigan could be formally approved as Ebola drug early 2015

      TOKYO, Japan - Shigetaka Komori, chief executive officer of Fujifilm Holdings Corp., attends a press conference in Tokyo, Japan, on Nov. 11, 2014, announcing that the company expects its Avigan anti-influenza drug to be formally approved early next year for treating people infected with the Ebola virus.
        Research to start on blood tests to detect 13 cancer types

        Research to start on blood tests to detect 13 cancer types

        TOKYO, Japan - Researchers announce the commencement of a project to develop ways of detecting 13 types of cancer from a single blood sample at a press conference in Tokyo on Aug. 18, 2014. Making the announcement were Kenji Kurata (L), president of the New Energy and Industrial Technology Development Organization, Tomomitsu Hotta (C), president of the National Cancer Center, and Tetsu Yonehara, head of Toray Industries Inc.'s New Frontiers Research Laboratories.
          Indian drug companies offer low-priced medicines to Japan

          Indian drug companies offer low-priced medicines to Japan

          TOKYO, Japan - Indian Commerce Secretary Rajeev Kher (R) speaks at a press conference in Tokyo on July 2, 2014. Kher, who attended the July 2 to 4 International Pharmaceutical Ingredients and Conference at Tokyo Big Site, said India can provide high-quality medicines at affordable prices to Japan, where medical expenses are expected to rise due to the aging population.
            Novartis management replaced

            Novartis management replaced

            TOKYO, Japan - David Epstein (L), president of Swiss pharmaceutical giant Novartis speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors. At right is new Novartis Pharma K.K. President Dirk Kosche.
              Novartis management replaced

              Novartis management replaced

              TOKYO, Japan - David Epstein, president of Swiss pharmaceutical giant Novartis holds a press conference in Tokyo on April 3, 2014. The Japanese sales arm of the company, Novartis Pharma K.K., announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
                Novartis management replaced

                Novartis management replaced

                TOKYO, Japan - Dirk Kosche, new president of Novartis Pharma K.K., speaks during a press conference in Tokyo on April 3, 2014. The Japanese sales arm of Swiss pharmaceutical giant Novartis announced that its president, Yoshiyasu Ninomiya, and two other top executives have resigned to take responsibility for its employees' inappropriate involvement in a clinical study led by medical doctors.
                  Prosecutors charge ex-Tokyo Gov. Inose

                  Prosecutors charge ex-Tokyo Gov. Inose

                  TOKYO, Japan - Naoki Inose, the former governor of Tokyo, holds a press conference in the capital on March 28, 2014, after prosecutors filed criminal charges against him over his receipt of 50 million yen from major hospital chain Tokushukai. Inose violated the public offices election law as he failed to report the money to the Tokyo metropolitan government's electoral management committee in the December 2012 gubernatorial election.
                    Prosecutors charge ex-Tokyo Gov. Inose

                    Prosecutors charge ex-Tokyo Gov. Inose

                    TOKYO, Japan - Naoki Inose, the former governor of Tokyo, apologizes during a press conference in the capital on March 28, 2014, after prosecutors filed criminal charges against him over his receipt of 50 million yen from major hospital chain Tokushukai. Inose violated the public offices election law as he failed to report the money to the Tokyo metropolitan government's electoral management committee in the December 2012 gubernatorial election.
                      Takeda chief apologizes over data misuse in drug ad

                      Takeda chief apologizes over data misuse in drug ad

                      TOKYO, Japan - Takeda Pharmaceutical Co. President Yasuchika Hasegawa apologizes during a press conference in Tokyo on March 3, 2014, over an advertisement for the company's blood pressure-lowering drug that made it appear the product is more powerful in suppressing diseases than other medicines.